These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23029296)

  • 1. An automatic refolding apparatus for preparative-scale protein production.
    Feng Y; Zhang M; Zhang L; Zhang T; Ding J; Zhuang Y; Wang X; Yang Z
    PLoS One; 2012; 7(9):e45891. PubMed ID: 23029296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidic chips with multi-junctions: an advanced tool in recovering proteins from inclusion bodies.
    Yamaguchi H; Miyazaki M
    Bioengineered; 2015; 6(1):1-4. PubMed ID: 25531187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refolding of recombinant human interferon alpha-2a from Escherichia coli by urea gradient size exclusion chromatography.
    Gao F; Shi L; Xu LX
    Prikl Biokhim Mikrobiol; 2013; 49(1):17-23. PubMed ID: 23662445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies.
    Yamaguchi H; Miyazaki M
    Biomolecules; 2014 Feb; 4(1):235-51. PubMed ID: 24970214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled oxidative protein refolding using an ion-exchange column.
    Langenhof M; Leong SS; Pattenden LK; Middelberg AP
    J Chromatogr A; 2005 Apr; 1069(2):195-201. PubMed ID: 15830945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urea-gradient protein refolding in size exclusion chromatography.
    Wang C; Cheng Y
    Curr Pharm Biotechnol; 2010 Apr; 11(3):289-92. PubMed ID: 20210741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative investigation on different refolding strategies of recombinant human tissue-type plasminogen activator derivative.
    Liu H; Zhou X; Zhang Y
    Biotechnol Lett; 2006 Apr; 28(7):457-63. PubMed ID: 16614926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling, simulation, and employing dilution-dialysis microfluidic chip (DDMC) for heightening proteins refolding efficiency.
    Kashanian F; Masoudi MM; Shamloo A; Habibi-Rezaei M; Moosavi-Movahedi AA
    Bioprocess Biosyst Eng; 2018 May; 41(5):707-714. PubMed ID: 29470707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High recovery refolding of rhG-CSF from Escherichia coli, using urea gradient size exclusion chromatography.
    Wang C; Wang L; Geng X
    Biotechnol Prog; 2008; 24(1):209-13. PubMed ID: 18179225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High hydrostatic pressure enables almost 100% refolding of recombinant human ciliary neurotrophic factor from inclusion bodies at high concentration.
    Wang Q; Liu Y; Zhang C; Guo F; Feng C; Li X; Shi H; Su Z
    Protein Expr Purif; 2017 May; 133():152-159. PubMed ID: 28323167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urea gradient size-exclusion chromatography enhanced the yield of lysozyme refolding.
    Gu Z; Su Z; Janson JC
    J Chromatogr A; 2001 May; 918(2):311-8. PubMed ID: 11407577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent.
    Upadhyay V; Singh A; Jha D; Singh A; Panda AK
    Microb Cell Fact; 2016 Jun; 15():100. PubMed ID: 27277580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adsorptive refolding of a highly disulfide-bonded inclusion body protein using anion-exchange chromatography.
    Chen Y; Leong SS
    J Chromatogr A; 2009 Jun; 1216(24):4877-86. PubMed ID: 19419725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-step refolding and purification of recombinant human tumor necrosis factor-α (rhTNF-α) using ion-exchange chromatography.
    Wang Y; Ren W; Gao D; Wang L; Yang Y; Bai Q
    Biomed Chromatogr; 2015 Feb; 29(2):305-11. PubMed ID: 24941919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refolding of difficult-to-fold proteins by a gradual decrease of denaturant using microfluidic chips.
    Yamaguchi H; Miyazaki M; Briones-Nagata MP; Maeda H
    J Biochem; 2010 Jun; 147(6):895-903. PubMed ID: 20207823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the refolding efficiency for proinsulin aspart inclusion body with optimized buffer compositions.
    Chen Y; Wang Q; Zhang C; Li X; Gao Q; Dong C; Liu Y; Su Z
    Protein Expr Purif; 2016 Jun; 122():1-7. PubMed ID: 26826314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Techno-economic evaluation of an inclusion body solubilization and recombinant protein refolding process.
    Freydell EJ; van der Wielen LA; Eppink MH; Ottens M
    Biotechnol Prog; 2011; 27(5):1315-28. PubMed ID: 21674819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative analysis of rapid methods for purification and refolding of recombinant bovine prion protein.
    Vrentas CE; Onstot S; Nicholson EM
    Protein Expr Purif; 2012 Apr; 82(2):380-8. PubMed ID: 22381461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of recombinant ovalbumin from inclusion bodies of Escherichia coli.
    Upadhyay V; Singh A; Panda AK
    Protein Expr Purif; 2016 Jan; 117():52-8. PubMed ID: 26390939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chaperone-assisted column refolding of gloshedobin with the use of refolding cocktail.
    Nian R; Tan L; Yoo IK; Choe WS
    J Chromatogr A; 2008 Dec; 1214(1-2):47-58. PubMed ID: 19004452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.